Follow
Ozden Altundag
Ozden Altundag
Verified email at baskent.edu.tr - Homepage
Title
Cited by
Cited by
Year
Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
SJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Yokoi, ...
New England Journal of Medicine 377 (20), 1919-1929, 2017
41332017
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label …
TSK Mok, YL Wu, I Kudaba, DM Kowalski, BC Cho, HZ Turna, G Castro, ...
The Lancet 393 (10183), 1819-1830, 2019
29922019
Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC
SJ Antonia, A Villegas, D Daniel, D Vicente, S Murakami, R Hui, T Kurata, ...
New England Journal of Medicine 379 (24), 2342-2350, 2018
26652018
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up
N Colombo, C Creutzberg, F Amant, T Bosse, A González-Martín, ...
International Journal of Gynecologic Cancer 26 (1), 2016
19262016
Pembrolizumab for persistent, recurrent, or metastatic cervical cancer
N Colombo, C Dubot, D Lorusso, MV Caceres, K Hasegawa, ...
New England Journal of Medicine 385 (20), 1856-1867, 2021
6092021
Lenvatinib plus pembrolizumab for advanced endometrial cancer
V Makker, N Colombo, A Casado Herráez, AD Santin, E Colomba, ...
New England Journal of Medicine 386 (5), 437-448, 2022
5192022
ESMO-ESGO-ESTRO endometrial consensus conference working group
N Colombo, C Creutzberg, F Amant, T Bosse, A Gonzalez-Martin, ...
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis …, 2016
3122016
Perianal infections in patients with leukemia: importance of the course of neutrophil count
Y Büyükaşık, OI Özcebe, N Sayınalp, IC Haznedaroğlu, ÖÖ Altundağ, ...
Diseases of the colon & rectum 41, 81-85, 1998
881998
Induction chemotherapy with cisplatin and 5‐fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of …
O Altundag, I Gullu, K Altundag, S Yalcin, E Ozyar, M Cengiz, F Akyol, ...
Head & neck 27 (1), 15-21, 2005
632005
Effect of surgical staging on 539 patients with borderline ovarian tumors: a Turkish Gynecologic Oncology Group study
T Guvenal, P Dursun, PS Hasdemir, M Hanhan, S Guven, H Yetimalar, ...
Gynecologic oncology 131 (3), 546-550, 2013
572013
Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy
O Altundag, DJ Stewart, FV Fossella, GD Ayers, W Wei, X Zhou, ...
Journal of Thoracic Oncology 2 (2), 141-146, 2007
562007
Interleukin-6 and C-reactive protein in metastatic renal cell carcinoma
O Altundag, K Altundag, E Gunduz
Journal of clinical oncology 23 (5), 2005
552005
The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer
A Ayhan, E Günakan, İ Alyazıcı, N Haberal, Ö Altundağ, P Dursun
Archives of Gynecology and Obstetrics 296, 989-995, 2017
502017
A Turkish Gynecologic Oncology Group study of fertility‐sparing treatment for early‐stage endometrial cancer
P Dursun, S Erkanli, AB Güzel, M Gultekin, NC Tarhan, O Altundag, ...
International Journal of Gynecology & Obstetrics 119 (3), 270-273, 2012
422012
Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experience
F Kose, A Besen, T Sumbul, A Sezer, C Karadeniz, U Disel, O Altundag, ...
Asian Pac J Cancer Prev 12 (5), 1185-1188, 2011
312011
Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant …
K Altundag, O Altundag, ET Elkiran, M Cengiz, Y Ozisik
Medical hypotheses 63 (1), 56-58, 2004
312004
DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients
O Altundag, K Altundag, M Gunduz
Medical hypotheses 63 (4), 684-687, 2004
312004
Management of Kikuchi‐Fujimoto Disease Using Glucocorticoid: A Case Report
S Yalcin, SK Toprak, B Erismis, O Altundag, H Ozdemir, N Topcuoglu
Case reports in medicine 2011 (1), 230840, 2011
292011
The relationship between glucose metabolism disorders and malignant thyroid disease
AO Duran, C Anil, A Gursoy, A Nar, O Altundag, NB Tutuncu
International journal of clinical oncology 18, 585-589, 2013
262013
Possible association between nanobacteria and malignant microcalcifications in breast cancer
K Altundag, O Altundag, S Akyurek, MA Atik
Breast J 12 (3), 287, 2006
262006
The system can't perform the operation now. Try again later.
Articles 1–20